Navigation Links
Intercell AG Announces Q3 2010 Results and Updates on R&D Progress and Management
Date:11/9/2010

velopment of the investigational Vaccine Enhancement Patch (VEP) system for Avian H5N1 Influenza vaccination as part of a collaborative agreement signed in December 2009. The initiation of a respective clinical trial is expected for end 2010/early 2011.
  • Intercell and Romark joined forces in combining therapies against Hepatitis C. The companies are designing a treatment that combines Intercell's investigational Hepatitis C vaccine, IC41, with Romark's antiviral drug, nitazoxanide - a combination Phase II trial is expected to start in H1 2011.

  • Management Effective October 1, 2010, Staph Leavenworth Bakali joined Intercell's Management Board as Chief Business Officer, with key responsibilities for the commercial aspects of the Company, directly leading Marketing & Sales, Corporate & Business Development, and Alliance Management.

    The full report can be downloaded at http://www.intercell.com/main/forinvestors/downloads/quarterly-reports/

    This communication expressly or implicitly contains certain forward-looking statements concerning Intercell AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors which could cause the actual results, financial condition, performance or achievements of Intercell AG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Intercell AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.


    '/>"/>

    SOURCE Intercell AG
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Intercell Reports Positive Results From Its Phase II Pseudomonas Aeruginosa Investigational Vaccine Study for Certain Hospital-Acquired Infections
    2. Romark and Intercell Join Forces in Combining Therapies Against Hepatitis C
    3. Intercell and Romark Join Forces in Combining Therapies Against Hepatitis C
    4. Intercell AG Appoints Staph Leavenworth Bakali as Chief Business Officer
    5. Intercell Acquires Antibody Technology Platform to Further Exploit Its Capabilities to Combat Infectious Diseases
    6. Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS
    7. Intercell Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae Vaccine
    8. Intercell AG Partners with Inclinix to Enroll 1800 Volunteers for Phase III Travelers Diarrhea Vaccine Study
    9. USD 12.5 m Funding for the Development of Intercells Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)
    10. Favourable Six Months Follow-Up Results From Intercells Phase II Therapeutic Hepatitis C Program
    11. Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/17/2014)... Revenue and earnings above the previous year - ... In the past 2013/14 fiscal year (ended 30 September ... 4.287 billion (last year: EUR 4.190 billion) despite unfavorable currency ... million. "Overall, 2013/14 was a successful fiscal year for the ... CEO of Carl Zeiss AG. "Thanks to our broad portfolio ...
    (Date:12/17/2014)... , The new ... of information concerning the biopharmaceutical Group,s national and international clinical ... to the recently launched institutional website that is receiving accolades ... by a new chapter in the fascinating story of Drug ... and panoramic hub on the world of clinical research, ranging ...
    (Date:12/17/2014)... HOUSTON , Dec. 17, 2014 ... Autism Approved ( http://bit.ly/1382OkS ) program seal ... autism community. The program highlights medical practices, materials ... considered "autism-community friendly." Children affected by ... that can be exacerbated by ingredients found in ...
    Breaking Medicine Technology:ZEISS Asserts its Position in Difficult Environment 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3
    (Date:12/21/2014)... Concept Plus, LLC. a SDB and 8(a) certified IT ... today announced it has been recognized by Washington Technology as ... fastest growing government contracting small businesses by calculating their compound ... the first year that Concept Plus, LLC., participated in the ... compound annual growth rate. “For Concept Plus to be recognized ...
    (Date:12/20/2014)... 20, 2014 Weddingshe.com has recently announced ... a site-wide promotion of special occasion dresses for the ... supplier of special occasion dresses for global women. Now, ... big discounts, up to 80% off. Among the new ... Short Sweet 16 Dress) is very popular. What’s more, ...
    (Date:12/20/2014)... 2014 The print component of Healthy ... distribution of approximately 160,000 copies and an estimated readership ... a vast social media strategy and across a network ... the digital version of the campaign, click here ... with the ladies of CTV’s The Social. Lainey ...
    (Date:12/20/2014)... the distinguished wedding dress manufacturer and retailer, has just ... has recently updated its official blog with the latest ... Angeldress Blog has recommended some new designs and ... in offering a huge selection of elegant products and ... are very carefully selected based on the design and ...
    (Date:12/20/2014)... Recently, AngelWeddingDress.com has introduced its special offer (called ... Christmas. In the promotion, all buyers worldwide can enjoy ... something special for the women who are looking for ... new collections of 2015 dresses have been unveiled recently. ... discounted prices. Visit our website now before they are ...
    Breaking Medicine News(10 mins):Health News:Concept Plus, LLC. Named One of Washington Technology’s Fast 50 2Health News:Tons of New-in Winter Sweet 16 Dresses from Weddingshe Online Now 2Health News:The ladies of The Social urge Canadian women to put themselves first over the holiday season and into the new year in Mediaplanet’s “Women’s Health” campaign 2Health News:Trendy Professional Wedding Apparel Recommended by Angeldress Blog 2Health News:AngelWeddingDress Has Introduced Its Special Offer For The Coming Christmas 2
    ... many health,recommendations in the media these days that it,s often ... make for better,health in the year ahead. ISSA polled their ... for their top,recommendations for the 10 best things their clients ... are the results of that survey:, 1 ...
    ... SMTS ) will release its financial results for the ... the opening of the market on,Wednesday, January 23, 2008. ... a conference call that will be webcast live at ... call, Bruce Barrett, Somanetics, president and chief,executive officer, and ...
    ... people cut down on excessive alcohol use , FRIDAY, Jan. ... dangers of alcohol abuse by an emergency room doctor or ... three drinks a week, new research shows. , Researchers trained ... tool, then applied it to almost 7,800 emergency patients in ...
    ... Inc. (NYSE:,DVA) announced today that it and Southwest ... to provide dialysis and vascular,access services, as well ... greater Phoenix area. The partnership will own and ... provide patients with,access to all available treatment modalities. ...
    ... precise cancer treatments ... form of volumetric arc therapy, PALO ALTO, Calif., ... has received FDA 510(k) clearances for its RapidArc(TM),radiotherapy technology, ... intensity-modulated radiation therapy (IMRT) two to,eight times faster and ...
    ... Pharmaceuticals,Inc. (NYSE: BRL ) today announced that ... from the U.S. Food and Drug Administration,(FDA) for ... hydrochloride) Tablets, 1mg (eq to 1 mg base). ... Roche,s patent on,December 28, 2007, and plans to ...
    Cached Medicine News:Health News:International Sports Sciences Association's Ten Best Resolutions for Better Health in 2008 2Health News:Somanetics Corporation to Release Fourth Quarter and Fiscal 2007 Financial Results and Host Conference Call January 23, 2008 2Health News:Brief Chat With ER Docs Can Curb Problem Drinking 2Health News:Varian Medical Systems Receives FDA 510(k) Clearance for RapidArc(TM) Radiotherapy Technology 2Health News:Varian Medical Systems Receives FDA 510(k) Clearance for RapidArc(TM) Radiotherapy Technology 3Health News:Varian Medical Systems Receives FDA 510(k) Clearance for RapidArc(TM) Radiotherapy Technology 4Health News:Barr Receives Approval for Generic KYTRIL(R) Tablets, 1mg (Base) 2Health News:Barr Receives Approval for Generic KYTRIL(R) Tablets, 1mg (Base) 3
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    Medicine Products: